This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Health Technology Remove Life Sciences Remove Pharmaceuticals Remove Regulations
article thumbnail

The Gains and Pains of Using AI in the Pharmaceutical Industry

HIT Consultant

OCTOBER 25, 2022

Contributing factors to this included larger trial sizes, the need to assess health technology, the requirement to provide data on comparative drugs’ effectiveness, and most importantly the high failure rate. A study in 2020 concluded that the estimated median capitalized research and development cost per product was $985 million.

Pharmaceuticals 98
Pharmaceuticals Regulations Doctors Health Technology 98
article thumbnail

Healthcare Is Changing, Right? Here’s 5 Reasons It’s Not.

HIT Consultant

JUNE 7, 2023

Kayt Leonard, Global Health Care and Life Sciences Strategic Advisor at SAS We hear it every day, right? Rising cost pressures from insurance companies, regulations aimed at reducing costs , and a generally complex and fragmented payment system can limit innovations that could improve patient outcomes. questionable.

Life Sciences 52
Life Sciences Healthcare Doctors Pharmaceuticals 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 19,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024